Literature DB >> 7910834

The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis.

D E Snider1, J R La Montagne.   

Abstract

Tuberculosis is the single leading cause of death from any single infectious agent. A world congress on tuberculosis was held to highlight the problem and to discuss recent scientific advances and global strategies for prevention and control. About one-third of the world population is latently infected with Mycobacterium tuberculosis. Over 8 million new cases and nearly 3 million deaths occur each year. The situation is deteriorating due, in part, to the human immunodeficiency virus pandemic and shifts in the age distribution of the population. Resistance to antituberculosis drugs has also emerged as an important obstacle to control. Tuberculosis control programs in many developing and some industrialized countries have inadequate resources to combat the problem. Despite these trends, successful strategies and programs have been developed that, if implemented, would likely significantly reduce morbidity and mortality. Furthermore, recent research findings suggest that technologic advances will soon lead to improved methods for prevention and control.

Entities:  

Mesh:

Year:  1994        PMID: 7910834     DOI: 10.1093/infdis/169.6.1189

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Evaluation of Cobas TaqMan MTB PCR for detection of Mycobacterium tuberculosis.

Authors:  Jeong Hyun Kim; Young Jae Kim; Chang-Seok Ki; Ji-Youn Kim; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

3.  Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

Authors:  C J De Haas; N M de Vos; M R Visser; H Snippe; J Verhoef
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Comparison of the genedia MTB detection kit and the cobas TaqMan MTB assay for detection of Mycobacterium tuberculosis in respiratory specimens.

Authors:  Hee Jae Huh; Hyeon Jeong Kwon; Chang-Seok Ki; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

5.  Evaluation of the Cobas TaqMan MTB test for the detection of Mycobacterium tuberculosis complex according to acid-fast-bacillus smear grades in respiratory specimens.

Authors:  Hee Jae Huh; Won-Jung Koh; Dong Joon Song; Chang-Seok Ki; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

Review 6.  Cost effectiveness of antituberculosis interventions.

Authors:  A Castelo; P A Mathiasi; R Iunes; A L Kritski; M Dalcolmo; F Fiuza de Melo; M Drummond
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

7.  Contribution of the polymerase chain reaction to the diagnosis of tuberculous infections in children.

Authors:  M Fauville-Dufaux; A Waelbroeck; P De Mol; B Vanfleteren; J Levy; P Debusschere; C M Farber
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

8.  Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation.

Authors:  B Springer; S Master; P Sander; T Zahrt; M McFalone; J Song; K G Papavinasasundaram; M J Colston; E Boettger; V Deretic
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

9.  Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.

Authors:  Ruth J Napier; Wasiulla Rafi; Mani Cheruvu; Kimberly R Powell; M Analise Zaunbrecher; William Bornmann; Padmini Salgame; Thomas M Shinnick; Daniel Kalman
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

10.  Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis.

Authors:  B Wieles; S Nagai; H G Wiker; M Harboe; T H Ottenhoff
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.